Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. north america
  4. immunotherapy
Show results for
Products
Services
Software
Applications

Companies


Refine by
Locations
Back to All Locations

  • North America
  • U.S. Virgin Islands
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
  • Custom manufacturer
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals
  • Monitoring and Testing
  • Agriculture
  • Health and Safety
  • University / Academia / Research
  • Defense
  • Commercial
  • Environmental
  • Manufacturing, Other
Employees

  • 101-1000
  • Over 1000

Immunotherapy Suppliers In North America

101 companies found
In North AmericaServing North AmericaNear North America

Fluxion Biosciences Inc

Fluxion Biosciences Inc

based inAlameda, CALIFORNIA (USA)
Fluxion delivers advanced solutions that transform complex cell-based and cell-free assays. Leading labs across the globe rely on Fluxion's instruments, kits, and lab services to research novel biology, accelerate drug discovery, and tailor ...
CONTACT SUPPLIER

Khloris Biosciences, Inc.

Khloris Biosciences, Inc.

based inMountain View, CALIFORNIA (USA)
iPSCs- a revolutionary discovery with untapped potential. We are dedicated to revolutionizing medical treatment and prevention of cancer and other diseases by harnessing the unlimited immunotherapeutic potential of induced pluripotent stem cells ...
CONTACT SUPPLIER

NeoGenomics Laboratories

NeoGenomics Laboratories

based inFort Myers, FLORIDA (USA)
NeoGenomics is a premier cancer diagnostic, pharma services, and information services company serving oncologists, pathologists, pharmaceutical companies, and academic centers in their pursuit of providing better futures for people living with ...
Anatomic Pathology

Anatomic Pathology

Histology, tissue staining using the latest in automated staining platforms, and digital pathology services form the foundation of a strong anatomic pathology program. Anatomic Pathology at NeoGenomics offers in-house comprehensive diagnostic ...
CONTACT SUPPLIER

Aptevo Therapeutics

Aptevo Therapeutics

based inSeattle, WASHINGTON (USA)
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative ADAPTIR™ and ADAPTIR-FLEX platform technologies to create therapeutic candidates designed to improve outcomes for ...
CONTACT SUPPLIER

Hemogenyx Pharmaceuticals plc

Hemogenyx Pharmaceuticals plc

based inLondon, UNITED KINGDOM
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx ...
HEMO-CAR-T Immunotherapy

HEMO-CAR-T Immunotherapy

Hemogenyx Pharmaceuticals has constructed Chimeric Antigen Receptor (CAR) programmed T cells, termed HEMO-CAR-T, for the potential treatment of Acute Myeloid Leukemia (AML). HEMO-CAR-T is made using Hemogenyx’s proprietary humanised monoclonal ...
CONTACT SUPPLIER

Metaclipse Therapeutics Corporation

Metaclipse Therapeutics Corporation

based inAtlanta, GEORGIA (US) (USA)
Metaclipse Therapeutics Corporation is developing novel personalized vaccine immunotherapies for cancer. MembrexTM, a proprietary platform approach tailored to each patient and their specific tumor, consists of ‘membrane vesicles’ prepared from a ...
Metaclipse VaxRex - Novel Personalized Vaccine Immunotherapies for Cancer

Metaclipse VaxRex - Novel Personalized Vaccine Immunotherapies for Cancer

Influenza (Target age 65+) and Influenza+ SARS-C0V-2 ...
CONTACT SUPPLIER

Immudex ApS

Immudex ApS

based inVirum, DENMARK
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial ...
Immudex - SARS-CoV-2 Panels

Immudex - SARS-CoV-2 Panels

Reliable Identification of SARS-CoV-2-Specific T-Cell Responses. T Cells Take the Lead in COVID-19. A deeper understanding of viral-specific T-cell responses to COVID-19 is needed to explore vaccine responses, long-term immunity, predict patients at ...
CONTACT SUPPLIER

NeoTherma Oncology

NeoTherma Oncology

based inWichita, KANSAS (USA)
Neotherma Oncology is led by experienced healthcare executives who are working toward the dream of more effective treatments for cancer. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treatment for deep solid ...
NeoTherma VectRx - Clinical Stage Medical Device

NeoTherma VectRx - Clinical Stage Medical Device

Our technology is based on applying a safe, non-invasive, non-ionizing electromagnetic field to produce local-regional hyperthermic temperatures in tumor tissue, intended to increase the effectiveness of anticancer radiotherapy, chemotherapy and ...
CONTACT SUPPLIER

Vedanta Biosciences, Inc

Vedanta Biosciences, Inc

based inCambridge, MASSACHUSETTS (USA)
The human body is an ecosystem. Trillions of microbes call us home. They form the human microbiome, which performs critical functions that preserve our health including modulating our immune system and providing colonization resistance against ...
Leveraging Breakthrough Discoveries in Immunology

Leveraging Breakthrough Discoveries in Immunology

From Ruslan Medzhitov's discovery of toll-like receptors (TLRs) as the key immune system receptors that detect infection, which spawned the field of innate immunity, to Dan Littman's efforts to identify and clone CD4 and CD8, molecules on the ...
CONTACT SUPPLIER

Immune-Onc Therapeutics, Inc.

Immune-Onc Therapeutics, Inc.

based inPalo Alto, CALIFORNIA (USA)
Immune-Onc is a clinical-stage company developing a novel class of myeloid checkpoint inhibitors. We believe myeloid checkpoints are the next frontier of immunotherapy for cancer. In collaboration with scientists, our research team is among the ...
Immune-Onc - Model IO-202 - (Anti-LILRB4) Mechanisms of Action in Hematologic Malignancies Program

Immune-Onc - Model IO-202 - (Anti-LILRB4) Mechanisms of Action in Hematologic Malignancies Program

Immune-Onc’s lead program is IO-202, an antagonist antibody targeting the myeloid checkpoint LILRB4 (also known as ILT3). Immune-Onc has a Phase I trial underway to evaluate IO-202 as a potential treatment for acute myeloid leukemia (AML) and ...
CONTACT SUPPLIER

Scopus BioPharma

Scopus BioPharma

based inNew York, NEW YORK (USA)
We are a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. Our mission is to improve patient outcomes and save lives. To achieve our mission, we seek to capitalize on ...
CONTACT SUPPLIER

Foundation Medicine, Inc.

Foundation Medicine, Inc.

based inCambridge, MASSACHUSETTS (USA)
Foundation Medicine was founded in 2010 with a mission to bring deep molecular information to the point of care for every patient living with advanced cancer. We’re an essential partner to patients, physicians, researchers, and biopharma ...
Comprehensive Genomic Profiling Tests Services

Comprehensive Genomic Profiling Tests Services

Discover tissue AND blood-based FDA-approved comprehensive genomic profiling testing for all solid tumors with FoundationOne®CDx and FoundationOne®Liquid CDx. In addition, FoundationOne®Heme is a laboratory developed test for hematologic ...
CONTACT SUPPLIER

Intrommune Therapeutics

Intrommune Therapeutics

based inNew York, NEW YORK (USA)
Intrommune is a New York City-based biotechnology company dedicated to simplifying allergy immunotherapy. Intrommune’s core technology enables immunotherapeutic agents to be delivered in a specially formulated toothpaste designed to incorporate and ...
Intrommune - Model OMIT - Oral Mucosal Immunotherapy for the Treatment of Food Allergies

Intrommune - Model OMIT - Oral Mucosal Immunotherapy for the Treatment of Food Allergies

Intrommune has developed a novel drug delivery platform—oral mucosal immunotherapy (OMIT)—for the treatment of food allergies. Therapeutic agents are embedding in fully functioning toothpaste so that treatment can be ...
CONTACT SUPPLIER

Ibio, Inc.

Ibio, Inc.

based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
IBIO - Model 101 - Immuno Oncology Therapeutics

IBIO - Model 101 - Immuno Oncology Therapeutics

Advances in the field of immuno-oncology have led to new and better treatment outcomes for a range of cancers, and particularly, blood cancers. However, even with the advent of checkpoint inhibitors as immunotherapies for solid ...
CONTACT SUPPLIER

LumaCyte, Inc.

LumaCyte, Inc.

based inCharlottesville, VIRGINIA (USA)
LumaCyte is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. This revolutionary ...
CONTACT SUPPLIER

Certara

Certara

based inPrinceton, NEW JERSEY (USA)
The drug discovery and development process is long and expensive with more failures than successes. At Certara, we anticipate and address your critical drug discovery and development risks and decisions using biosimulation, technology and services. ...
Simcyp - Biological Medicines Simulator

Simcyp - Biological Medicines Simulator

Biological medicines (“biologics” or “large molecule drugs”) now account for 30% of new drug approvals and up to 50% of the pharmaceutical industry’s pipeline. Biologics differ from small molecules because they are much ...
CONTACT SUPPLIER

UroGen Pharma, Inc.

UroGen Pharma, Inc.

based inPrinceton, NEW YORK (USA)
We are a biopharmaceutical company dedicated to building novel solutions that treat urothelial and specialty cancers. Our breakthrough therapy and innovative clinical pipeline aim to maximize the potential benefit of local delivery with our novel ...
UroGen - Model UGN-301 + UGN-201 (TLR 7 Agonist) - High-Grade Non-Muscle-Invasive Bladder Cancer (NMIBC)

UroGen - Model UGN-301 + UGN-201 (TLR 7 Agonist) - High-Grade Non-Muscle-Invasive Bladder Cancer (NMIBC)

UGN-301 is UroGen’s in-licensed anti-CTLA-4 antibody (zalifrelimab). UGN-201 is our proprietary formulation of imiquimod, a toll-like receptor 7 (TLR 7) agonist. When combined, these medicines stimulate both the innate (UGN-201) and adaptive ...
CONTACT SUPPLIER

MedChemExpress LLC (MCE)

MedChemExpress LLC (MCE)

based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
MedChemExpress - Model Ditiocarb sodium - 148-18-5

MedChemExpress - Model Ditiocarb sodium - 148-18-5

Ditiocarb sodium (Sodium diethyldithiocarbamate) is an accelerator of the rate of copper cementation. Sodium diethyldithiocarbamate reduces the incidence of HIV infection, and also enhances adjuvant immunoresearch of high risk breast ...
CONTACT SUPPLIER

Immune Biosolutions Inc.

Immune Biosolutions Inc.

based inSherbrooke, QUEBEC (CANADA)
At Immune Biosolutions (IBio), we strongly believe that biologics can transform and save lives. Leveraging our technology platforms, we hack the immune system of chickens to discover and engineer the next generation of immunotherapies. We create ...
Immune Biosolutions - Antibody Discovery at a Pandemic Pace

Immune Biosolutions - Antibody Discovery at a Pandemic Pace

Leveraging our technology platforms, we hack the immune system of chickens to discover and engineer the next generation of immunotherapies. ...
CONTACT SUPPLIER

Immatics N.V.

Immatics N.V.

based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
ACTallo - Off-the-shelf Adoptive Cell Therapy

ACTallo - Off-the-shelf Adoptive Cell Therapy

ACTallo® is a process developed by Immatics for the manufacture of allogeneic, off-the-shelf, TCR-engineered cellular therapies derived from healthy donors’ gamma delta T ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT